Edwards Lifesciences | EW - Eps Gewinn Pro Aktie

Aktienkurs
84.55
Täglich Wechseln
0.40 0.48%
Monatlich
6.35%
Jährlich
11.93%
Q2 Prognose
82.35

Fiscal Kalender Aktuell Konsens Zuletzt Datum
FY2026Q1 Mar/2026 0.78 0.73 0.64 Apr/23
FY2025Q4 Dec/2025 0.58 0.62 0.59 Feb/10
FY2025Q3 Sep/2025 0.67 0.59 0.67 Oct/30
FY2025Q2 Jun/2025 0.67 0.62 0.70 Jul/24
FY2025Q1 Mar/2025 0.64 0.59 0.66 Apr/23




Eps Veränderung Datum
Abbott USD 1.15 0.35 2026-03
Artivion USD -0.02 0.2 2025-12
AtriCure USD 0.06 0.07 2025-12
Baxter International USD 0.44 0.25 2025-12
Becton, Dickinson and Co. USD 2.91 1.05 2025-12
Boston Scientific USD 0.8 0 2026-03
Cooper Companies USD 0.66 0.26 2025-12
Dexcom USD 0.68 0.07 2025-12
Edwards Lifesciences USD 0.78 0.2 2026-03
Globus Medical USD 1.28 0.1 2025-12
ICU Medical USD 1.91 0.12 2025-12
Inogen USD -0.25 0.01 2024-09
Insulet USD 1.44 0.2 2025-12
Integra LifeSciences USD 0.83 0.29 2025-12
Intuitive Surgical USD 2.5 0.03 2026-03
J&J USD 2.7 0.24 2026-03
Masimo USD -0.18 1.5 2025-12
Medtronic USD 1.36 0.29 2026-01
Merit Medical Systems USD 1.04 0.12 2025-12
Stryker USD 4.47 1.28 2025-12
Tandem Diabetes Care USD -0.01 0.3 2025-12
Teleflex USD 1.93 1.74 2025-12
Zimmer Biomet Holdings USD 2.42 0.52 2025-12